Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Brimstone is a climate technology company that has developed a breakthrough process to produce carbon-neutral and carbon-negative Portland cement. While not a traditional healthcare or pharmaceutical company, Brimstone utilizes industrial biotechnology and chemical engineering principles to replace carbon-intensive limestone with calcium silicate rocks. This process produces the same structural cement used globally but generates magnesium compounds as a byproduct that actively absorb CO2 from the atmosphere. The company is currently scaling its technology to decarbonize one of the world's most carbon-intensive industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Brimstone.